UK Radiation Oncology Market Size & Outlook, 2020-2028
UK radiation oncology market, 2017-2028 (US$M)
Related Markets
UK radiation oncology market highlights
- The UK radiation oncology market generated a revenue of USD 266.0 million in 2020 and is expected to reach USD 500.6 million by 2028.
- The UK market is expected to grow at a CAGR of 8.2% from 2021 to 2028.
- In terms of segment, external beam radiationtherapy was the largest revenue generating type in 2020.
- Internal Beam Radiation Therapy is the most lucrative type segment registering the fastest growth during the forecast period.
Radiation oncology market data book summary
| Market revenue in 2020 | USD 266.0 million |
| Market revenue in 2028 | USD 500.6 million |
| Growth rate | 8.2% (CAGR from 2020 to 2028) |
| Largest segment | External beam radiationtherapy |
| Fastest growing segment | Internal Beam Radiation Therapy |
| Historical data | 2017 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | External Beam RadiationTherapy, Internal Beam Radiation Therapy |
| Key market players worldwide | Siemens Healthineers AG ADR, Elekta AB ADR, BD, Accuray Inc, IBA RadioPharma Solutions, IsoRay, MeVis Medical Solutions AG, Nordion, Ntp Radioisotopes, Curium Pharma, ViewRay |
Other key industry trends
- In terms of revenue, UK accounted for 3.5% of the global radiation oncology market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Europe, Germany radiation oncology market is projected to lead the regional market in terms of revenue in 2028.
- UK is the fastest growing regional market in Europe and is projected to reach USD 500.6 million by 2028.
External beam radiationtherapy was the largest segment with a revenue share of 70.3% in 2020. Horizon Databook has segmented the UK radiation oncology market based on external beam radiationtherapy, internal beam radiation therapy covering the revenue growth of each sub-segment from 2017 to 2028.
As per Macmillan Cancer Support, the proportion of cancer patients in the UK is estimated to be around 47% of the population between 2020 and 2030. The most common form of cancer in the UK is breast cancer. The National Awareness and Early Diagnosis Initiative (NAEDI).
which involved the NHS England, Cancer Research UK, Public Health England, and the Department of Health, promotes early diagnosis of cancer and increased access to proper treatment. This initiative also aims to reduce deaths due to cancer.
The Cancer Research UK and BUPA foundation entered into a partnership to start Cancer Preventive Initiative, which is intended to conduct research on lifestyle and behavioral changes to prevent cancer. The Cancer Reform Strategy mentioned that 40% or less patients in England.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiation Oncology Market Scope
Radiation Oncology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK radiation oncology market size, by type, 2017-2028 (US$M)
UK Radiation Oncology Market Outlook Share, 2020 & 2028 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
